Biomedicine

Found results: 2481

Biomedicine

Troponin T will warn about the risk of cardiovascular diseases

A new method for determining troponin T in the blood, 10 times more sensitive than the existing ones, will allow determining the likelihood of developing diseases of the cardiovascular system and timely, in 10-15 years, take measures to prevent them.

17.11.2010
Biomedicine

Cancer drugs: each case is unique

For the occurrence of cancer, signal cascades are of the greatest importance, which stimulate the division of cells in the embryo, but they are not turned on in an adult. The search for substances capable of suppressing their work is one of the promising approaches to the development of drugs against cancer.

16.11.2010
Biomedicine

Shaped blood elements from fibroblasts

Researchers from McMaster University have managed to reprogram fibroblasts into all types of blood cells without the intermediate stage of induced pluripotent stem cells.

08.11.2010
Biomedicine

Genetics is the key to cancer treatment

Carlo Croce, a world–renowned specialist in the study of cancer genetics, professor at Ohio State University and director of the Human Cancer Genetics Program, spoke about his vision of the future of cancer treatment and the reasons for the effectiveness of science in the United States.

03.11.2010
Biomedicine

Vaccine for cancer treatment: another hope

Specialists of I.M.Sechenov I Moscow State Medical University have proved the effectiveness of the method they developed for obtaining individual vaccines for cancer treatment on laboratory animals. Clinical trials are next in line.

27.10.2010
Biomedicine

Gene therapy against depression

Perhaps the time is not far off when gene therapy will become a remedy for depression. In any case, the results of recent research in this area set up specialists in an optimistic mood.

26.10.2010
Biomedicine

Gene therapy of atherosclerosis is almost not fiction

In mice with an atherosclerosis model, after the introduction of a virus with a healthy copy of the gene, the number of cholesterol plaques in the vessels turned out to be ten times less than in animals of the control group. Maybe people with high cholesterol will soon be treated with gene therapy?

20.10.2010
Biomedicine

In Vitro fertilization: only healthy eggs!

Two women who took part in the first study of a genetic test that allows culling eggs with chromosomal abnormalities before IVF, successfully gave birth to healthy children.

19.10.2010
Biomedicine

Trojan Pill: Continued

For the targeted administration of drugs into the right organ and even inside the cell, scientists have created "Trojan pills" – microscopic capsules made of the thinnest layers of polymers with different properties.

18.10.2010
Biomedicine

JAML – activator of epithelial immunity

The detection of a molecule that activates gamma/delta T lymphocytes gives pharmacists a potential target for controlling the healing processes of damaged epithelium.

06.09.2010
Biomedicine

Gene therapy against lower limb ischemia

For more than 20 years, scientists have been developing non-surgical methods for the treatment of lower limb ischemia. Gene therapy drugs are now considered one of the most promising areas in this field.

06.09.2010
Biomedicine

Antidepressants based on ketamine?

Finding out the molecular mechanism by which ketamine quickly and effectively eliminates the symptoms of depression opens the way for the creation of antidepressants similar to ketamine in action, but more convenient and safe.

25.08.2010
Biomedicine

Resveratrol and sirtuins: to be continued

The discussion continues about the ability of resveratrol and its analogues to activate the work of sirtuins "in vitro" and in a living organism.

24.08.2010
Biomedicine

Genentech's Success Story

Since its birth, Genentech has not conceded leadership in biotechnology. For twelve years in a row, including in 2010, Fortune has named Genentech one of the best companies worth working for, and last year Science named it the best employer in biotech.

23.08.2010
Biomedicine

A complete and final victory over the flu?

A new vaccination strategy to ensure lifelong immunity from all strains of the influenza virus is already undergoing the first stage of clinical trials.

16.07.2010
Biomedicine

A false target for cancer cells

It was the SID decoy protein molecule (English decoy – a false target), which bound to the regulatory protein, preventing it from starting the work of genes that provide a cancer cell with rapid growth and resistance to drugs.

12.07.2010